{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:57:33Z","timestamp":1783605453195,"version":"3.55.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Salidroside (SDS), a phenylpropanoid glycoside, is an antioxidant component isolated from the traditional Chinese medicine <jats:italic>Rhodiola rosea<\/jats:italic> and has multifunctional bioactivities, particularly possessing potent hepatoprotective function. Non-alcoholic steatohepatitis (NASH) is one of the most prevalent chronic liver diseases worldwide, but it still lacks efficient drugs. This study aimed to assess the preventive and therapeutic effects of SDS on NASH and its underlying mechanisms in a mouse model subjected to a methionine- and choline-deficient (MCD) diet.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>C57BL\/6J mice were fed an MCD diet to induce NASH. During or after the formation of the MCD-induced NASH model, SDS (24\u00a0mg\/kg\/day) was supplied as a form of diet for 4\u00a0weeks. The histopathological changes were evaluated by H&amp;amp;E staining. Oil Red O staining and Sirius Red staining were used to quantitatively determine the lipid accumulation and collagen fibers in the liver. Serum lipid and liver enzyme levels were measured. The morphology of autophagic vesicles and autophagosomes was observed by transmission electron microscopy (TEM), and qRT-PCR and Western blotting were used to detect autophagy-related factor levels. Immunohistochemistry and TUNEL staining were used to evaluate the apoptosis of liver tissues. Flow cytometry was used to detect the composition of immune cells. ELISA was used to evaluate the expression of serum inflammatory factors. Transcript\u2013proteome sequencing, molecular docking, qRT-PCR, and Western blotting were performed to explore the mechanism and target of SDS in NASH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The oral administration of SDS demonstrated comprehensive efficacy in NASH. SDS showed both promising preventive and therapeutic effects on NASH <jats:italic>in vivo<\/jats:italic>. SDS could upregulate autophagy, downregulate apoptosis, rebalance immunity, and alleviate inflammation to exert anti-NASH properties. Finally, the results of transcript\u2013proteome sequencing, molecular docking evaluation, and experimental validation showed that SDS might exert its multiple effects through targeting PPAR\u03b1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings revealed that SDS could regulate liver autophagy and apoptosis, regulating both innate immunity and adaptive immunity and alleviating inflammation in NASH prevention and therapy via the PPAR pathway, suggesting that SDS could be a potential anti-NASH drug in the future.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1433076","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T04:39:13Z","timestamp":1727843953000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Salidroside may target PPAR\u03b1 to exert preventive and therapeutic activities on NASH"],"prefix":"10.3389","volume":"15","author":[{"given":"Xueru","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shousheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongning","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.intimp.2017.05.035","article-title":"Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling","volume":"49","author":"Afrin","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4314\/ahs.v23i2.59","article-title":"The epidemiology and characteristics of patients with diabetes with or without NASH: a systematic review","volume":"23","author":"Aldossari","year":"2023","journal-title":"Afr. Health Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/molecules27030858","article-title":"A comparison of the gene expression profiles of non-alcoholic fatty liver disease between animal models of a high-fat diet and methionine-choline-deficient diet","volume":"27","author":"Alshawsh","year":"2022","journal-title":"Molecules"},{"key":"B4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejphar.2017.04.011","article-title":"Salidroside protects rat liver against ischemia\/reperfusion injury by regulating the GSK-3\u03b2\/Nrf2-dependent antioxidant response and mitochondrial permeability transition","volume":"806","author":"Cai","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"154338","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"B7","doi-asserted-by":"publisher","first-page":"154241","DOI":"10.1016\/j.phymed.2022.154241","article-title":"Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-\u03baB\/NLRP3 signaling pathway","volume":"104","author":"Deng","year":"2022","journal-title":"Phytomedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of inflammatory cytokines with non-alcoholic fatty liver disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"110458","DOI":"10.1016\/j.biopha.2020.110458","article-title":"Salidroside as a potential neuroprotective agent for ischemic stroke: a review of sources, pharmacokinetics, mechanism and safety","volume":"129","author":"Fan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.7150\/ijbs.65044","article-title":"Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies","volume":"18","author":"Fang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.2147\/DDDT.S162950","article-title":"Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-\u03baB and TGF-\u03b21\/Smad3 pathways","volume":"12","author":"Feng","year":"2018","journal-title":"Drug Des. devel. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher's guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat. Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"121793","DOI":"10.1016\/j.lfs.2023.121793","article-title":"Salidroside alleviates acetaminophen-induced hepatotoxicity via Sirt1-mediated activation of Akt\/Nrf2 pathway and suppression of NF-\u03baB\/NLRP3 inflammasome axis","volume":"327","author":"Gao","year":"2023","journal-title":"Life Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/17474124.2023.2175671","article-title":"Bidirectional association between NAFLD and gallstone disease: a systematic review and meta-analysis of observational studies","volume":"17","author":"Gu","year":"2023","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: definition and subtypes","volume":"29","author":"Han","year":"","journal-title":"Clin. Mol. Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/biof.1987","article-title":"Nomilin and its analogue obacunone alleviate NASH and hepatic fibrosis in mice via enhancing antioxidant and anti-inflammation capacity","volume":"49","author":"Han","year":"","journal-title":"Biofactors"},{"key":"B19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"314081","DOI":"10.1155\/2014\/314081","article-title":"Salidroside attenuates concanavalin A-induced hepatitis via modulating cytokines secretion and lymphocyte migration in mice","volume":"2014","author":"Hu","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1002\/hep.32066","article-title":"Salidroside activates the AMP-activated protein kinase pathway to suppress nonalcoholic steatohepatitis in mice","volume":"74","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.jcmgh.2022.02.019","article-title":"The critical and diverse roles of CD4-CD8- double negative T cells in nonalcoholic fatty liver disease","volume":"13","author":"Li","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"21581","DOI":"10.1021\/acs.est.3c05010","article-title":"PPAR\u03b1 senses bisphenol S to trigger ep300-mediated autophagy blockage and hepatic steatosis","volume":"57","author":"Liang","year":"2023","journal-title":"Environ. Sci. Technol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/nu15081892","article-title":"Predictive role of neutrophil-percentage-to-albumin ratio (NPAR) in nonalcoholic fatty liver disease and advanced liver fibrosis in nondiabetic US adults: evidence from NHANES 2017-2018","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","first-page":"120949","DOI":"10.1016\/j.lfs.2022.120949","article-title":"Rhodiola activates macrophage migration inhibitory factor to alleviate non-alcoholic fatty liver disease","volume":"308","author":"Liu","year":"2022","journal-title":"Life Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","article-title":"Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Acta. Pharm. Sin. B"},{"key":"B28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41574-022-00711-5","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.3892\/mmr.2019.10115","article-title":"Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway","volume":"19","author":"Lu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.3390\/cancers15225458","article-title":"From non-alcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): epidemiology, incidence, predictions, risk factors, and prevention","volume":"15","author":"Motta","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1111\/liv.15441","article-title":"Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice","volume":"42","author":"Ni","year":"2022","journal-title":"Liver Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"100346","DOI":"10.1016\/j.jhepr.2021.100346","article-title":"New targets for NAFLD","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e202200401","DOI":"10.1002\/cbdv.202200401","article-title":"Salidroside in the treatment of NAFLD\/NASH","volume":"19","author":"Qu","year":"2022","journal-title":"Chem. Biodivers."},{"key":"B38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/nu9030198","article-title":"The combination of blueberry juice and probiotics ameliorate non-alcoholic steatohepatitis (NASH) by affecting SREBP-1c\/PNPLA-3 pathway via PPAR-\u03b1","volume":"9","author":"Ren","year":"2017","journal-title":"Nutrients"},{"key":"B40","doi-asserted-by":"publisher","first-page":"109726","DOI":"10.1016\/j.biopha.2019.109726","article-title":"Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K\/Akt\/mTOR pathway","volume":"122","author":"Rong","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","article-title":"Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis","volume":"57","author":"Savage","year":"2024","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","first-page":"9682","DOI":"10.3390\/ijms21249682","article-title":"Cell death in liver diseases: a review","volume":"21","author":"Shojaie","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jhep.2023.07.004","article-title":"Treating NASH by targeting peroxisome proliferator-activated receptors","volume":"79","author":"Staels","year":"2023","journal-title":"J. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/molecules21111490","article-title":"Salidroside regulates inflammatory response in raw 264.7 macrophages via TLR4\/TAK1 and ameliorates inflammation in alcohol binge drinking-induced liver injury","volume":"21","author":"Sun","year":"2016","journal-title":"Molecules"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S2468-1253(23)00066-3","article-title":"Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"8","author":"Tincopa","year":"2023","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.3390\/ijms23179954","article-title":"Caffeine inhibits NLRP3 inflammasome activation by downregulating TLR4\/MAPK\/NF-\u03baB signaling pathway in an experimental NASH model","volume":"23","author":"Vargas-Pozada","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jcmgh.2021.08.019","article-title":"Activated natural killer cell promotes nonalcoholic steatohepatitis through mediating JAK\/STAT pathway","volume":"13","author":"Wang","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"15787","DOI":"10.1021\/acs.jafc.2c06297","article-title":"Folic acid protects against hyperuricemia in C57bl\/6J mice via ameliorating gut-kidney Axis dysfunction","volume":"70","author":"Wang","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e153831","DOI":"10.1172\/jci.insight.153831","article-title":"Multicytokine-producing CD4+ T cells characterize the livers of patients with NASH","volume":"8","author":"Woestemeier","year":"2023","journal-title":"JCI Insight"},{"key":"B51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-981-10-8684-7_10","article-title":"Autophagy, NAFLD and NAFLD-related HCC","volume":"1061","author":"Wu","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"115331","DOI":"10.1016\/j.ecoenv.2023.115331","article-title":"Salidroside ameliorates acetaminophen-induced acute liver injury through the inhibition of endoplasmic reticulum stress-mediated ferroptosis by activating the AMPK\/SIRT1 pathway","volume":"262","author":"Xu","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B54","doi-asserted-by":"publisher","first-page":"154762","DOI":"10.1016\/j.phymed.2023.154762","article-title":"Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2\/GPX4 axis in SAMP8 mice","volume":"114","author":"Yang","year":"2023","journal-title":"Phytomedicine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"109268","DOI":"10.1016\/j.cbi.2020.109268","article-title":"Salidroside: a review of its recent advances in synthetic pathways and pharmacological properties","volume":"339","author":"Zhang","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"B57","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1126\/science.aay0542","article-title":"An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis","volume":"367","author":"Zhao","year":"2020","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.31083\/j.fbl2901030","article-title":"Autophagy, ferroptosis, apoptosis and pyroptosis in metabolic dysfunction-associated steatotic liver disease","volume":"29","author":"Zhao","year":"2024","journal-title":"Front. Biosci. Landmark Ed."},{"key":"B59","doi-asserted-by":"publisher","first-page":"967410","DOI":"10.3389\/fimmu.2022.967410","article-title":"CD4+ T cell activation and inflammation in NASH-related fibrosis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1104943","DOI":"10.3389\/fimmu.2022.1104943","article-title":"The role of Th17 cells in endocrine organs: involvement of the gut, adipose tissue, liver and bone","volume":"13","author":"Zi","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1433076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T04:39:15Z","timestamp":1727843955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1433076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":60,"alternative-id":["10.3389\/fphar.2024.1433076"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1433076","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"article-number":"1433076"}}